OCGN News

Latest breaking news and updates for OCGN stock.

Track all markets on TradingView

Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU410ST—Modifier Gene Therapy for Stargardt Disease

MALVERN, Pa., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced th...

How might this EMA decision influence the stock’s volatility and trading volume in the next weeks? What is the expected impact on Ocugen’s earnings guidance for 2025‑2026 due to this regulatory milestone? What are the potential impacts on existing and upcoming clinical trial timelines for other Ocugen gene therapy programs?
Clinical trials
24 days ago
Read more globenewswire

Ocugen, Inc. Announces Closing of $20 Million Registered Direct Offering of Common Stock and Warrants

MALVERN, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced th...

How will the offering impact the company’s balance sheet, debt levels, and overall valuation metrics? Could the warrant call feature lead to a short‑cover rally or squeeze if the VWAP target is met? What is the market’s perception of the company’s pipeline and growth prospects after securing this additional capital?
Offering
25 days ago
Read more globenewswire

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants

MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced th...

How does this offering compare to recent capital‑raising activities by peer biotech companies in terms of size, pricing, and warrant structures? Are there any covenants or lock‑up periods associated with the securities purchase agreement that could affect future share sales or insider activity? What is the likely impact on the stock’s liquidity and bid‑ask spread once the offering is completed?
Capital raising
29 days ago
Read more globenewswire